tiprankstipranks
Trending News
More News >

Peter Presland Insider Profile

4 Followers
Peter Presland, Director at Redx Pharma, holds 3.40M shares in Oxford BioDynamics (Ticker: GB:OBD), holds 266.23K shares in Redx Pharma (Ticker: GB:REDX). Most recently, Peter Presland Bought ― shares of Oxford BioDynamics on Apr 10, 2025 for an estimated value of 14.95K.
tipranks
Peter Presland

Peter Presland
Redx Pharma (REDX)
Director

Ranked #14,501 out of 102,830 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+36.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£17K
100.00%
A breakdown of Peter Presland's holdings

Insider Roles

Oxford BioDynamics
(OBD)
Director
Roles that Peter Presland holds in companies

Most Profitable Insider Trade

Stock:
Redx Pharma
(REDX)
Rating:Informative Buy
Date:Jul 01, 2020 - Jul 01, 2021
Return:+144.10%
The most profitable trade made by Peter Presland

Peter Presland's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
REDX
Redx Pharma
Dec 22, 2020
Informative Buy
15.33K
£39.93K
Oxford BioDynamics
Apr 10, 2025
Director
Informative Buy
14.95K
£16.99K
List of latest transactions for each holding click on a transaction to see Peter Presland's performance on stock

Peter Presland insider profile FAQ

What is the percentage of profitable transactions made by Peter Presland?
The percentage of profitable transactions made by Peter Presland is 75%.
    What is the average return per transaction made by Peter Presland?
    The average return per transaction made by Peter Presland is 36.90%.
      What stocks does Peter Presland hold?
      Peter Presland holds: GB:REDX, GB:OBD stocks.
        What was Peter Presland’s latest transaction?
        Peter Presland latest transaction was an Informative Buy of 14.95K.
          What was Peter Presland's most profitable transaction?
          Peter Presland’s most profitable transaction was an Informative Buy of GB:REDX stock on July 1, 2020. The return on the trade was 144.10%.
            What is Peter Presland's role in Redx Pharma?
            Peter Presland's role in Redx Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.